Subscribe to Newsletter

Search

Reset Filter

4176 search results for ‘*’

Discovery & Development Drug Discovery

Venom: The Last Advance

| Rob Coker | 2 min read

How snake venom, genomic data, and deep learning computation methods have combined to bring new advances in drug discovery.


Discovery & Development Drug Discovery

Examining the Effectiveness of Antidepressants

| Stephanie Vine | 2 min read

Review shows that antidepressants have significant effect when treating generalized anxiety disorder.


Manufacture Advanced Medicine

Integrating Technology and Robotics in CGT Manufacturing

| 7 min read

How the right partnerships are helping streamline CGT manufacturing through robotics and digital tools.


Manufacture Packaging

Vial Wars

| Stephanie Vine | 2 min read

Study investigates why vial choices matters for frozen biopharmaceutical storage.


Manufacture Small Molecules

2025 Predictions for RNA Therapeutics

| Kate Broderick | 5 min read

So much has already been achieved with RNA – and it’s only going to get better.

Business & Regulation Standards & Regulation

Trump’s Tariffs

| Rob Coker | 3 min read

US-based pharmaceutical associations fear the supply chain repercussions of tariffs, and offer advice for a more sustainable alternative.

Manufacture Technology and Equipment

Using AI to Conquer the Undruggable

| 2 min read

AI is set to be a key disruptor in the pharma industry. Here are two perspectives on how it could change drug development.

Business & Regulation Bioprocessing - Upstream & Downstream

Sanofi’s Push for Pricing Flexibility in the UK

| 6 min read

We speak with Sanofi’s Anju Bhalla about its appeal against NICE’s final draft guidance for Sarclisa.

Business & Regulation Standards & Regulation

Robert F. Kennedy Jr Nomination Advances

| Stephanie Vine | 2 min read

Senate committee votes in favor of the nomination; full Senate vote will be next.

Business & Regulation Profession

Maintaining Momentum

| 4 min read

Being part of the cell and gene therapy field is an incredible privilege, according to Frank Mathias, CEO, Oxford Biomedica.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register